loadpatents
Patent applications and USPTO patent grants for Blizzard; Charles D..The latest application filed is for "pulmonary pharmaceutical formulations".
Patent | Date |
---|---|
Pulmonary Pharmaceutical Formulations App 20220296612 - Blizzard; Charles D. ;   et al. | 2022-09-22 |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) App 20220296559 - Ward; Kevin L. ;   et al. | 2022-09-22 |
Ocular implant containing a tyrosine kinase inhibitor Grant 11,439,592 - Blizzard , et al. September 13, 2 | 2022-09-13 |
Shape changing drug delivery devices and methods Grant 11,413,250 - Jarrett , et al. August 16, 2 | 2022-08-16 |
Compositions And Methods For Treating Ocular Diseases App 20220218643 - Blizzard; Charles D. ;   et al. | 2022-07-14 |
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine App 20220202706 - Blizzard; Charles D. ;   et al. | 2022-06-30 |
Drug delivery from hydrogels Grant 11,369,591 - Jarrett , et al. June 28, 2 | 2022-06-28 |
Ocular Insert Containing A Glucocorticoid App 20220183969 - Blizzard; Charles D. ;   et al. | 2022-06-16 |
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Grant 11,331,267 - Blizzard , et al. May 17, 2 | 2022-05-17 |
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Grant 11,291,627 - Blizzard , et al. April 5, 2 | 2022-04-05 |
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine App 20220087932 - Blizzard; Charles D. ;   et al. | 2022-03-24 |
Sustained Release Biodegradable Intracanalicular Inserts Comprising A Hydrogel And Cyclosporine App 20220087931 - Blizzard; Charles D. ;   et al. | 2022-03-24 |
Ocular Implant Containing A Tyrosine Kinase Inhibitor App 20220079876 - Blizzard; Charles D. ;   et al. | 2022-03-17 |
Ocular Implant Containing A Tyrosine Kinase Inhibitor App 20210308043 - Blizzard; Charles D. ;   et al. | 2021-10-07 |
Compositions and Methods for Treating Ocular Diseases App 20210251893 - Blizzard; Charles D. ;   et al. | 2021-08-19 |
Shape Changing Drug Delivery Devices And Methods App 20210128478 - Jarrett; Peter ;   et al. | 2021-05-06 |
Hydrogel Implants For Lowering Intraocular Pressure App 20200337990 - Goldstein; Michael ;   et al. | 2020-10-29 |
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants App 20200337989 - Jarrett; Peter ;   et al. | 2020-10-29 |
Shape changing drug delivery devices and methods Grant 10,786,462 - Jarrett , et al. September 29, 2 | 2020-09-29 |
Shape Changing Drug Delivery Devices And Methods App 20200030241 - Jarrett; Peter ;   et al. | 2020-01-30 |
Shape changing drug delivery devices and methods Grant 10,420,724 - Jarrett , et al. Sept | 2019-09-24 |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) App 20190022053 - Ward; Kevin L. ;   et al. | 2019-01-24 |
Intracameral Drug Delivery Depots App 20180085307 - Sawhney; Amarpreet S. ;   et al. | 2018-03-29 |
Shape Changing Drug Delivery Devices And Methods App 20170143636 - Jarrett; Peter ;   et al. | 2017-05-25 |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) App 20170007571 - Ward; Kevin L. ;   et al. | 2017-01-12 |
Drug Delivery From Hydrogels App 20160331738 - Jarrett; Peter ;   et al. | 2016-11-17 |
Pulmonary Pharmaceutical Formulations App 20160151393 - Blizzard; Charles D. ;   et al. | 2016-06-02 |
Pulmonary Pharmaceutical Formulations App 20140148424 - Blizzard; Charles D. ;   et al. | 2014-05-29 |
Pulmonary pharmaceutical formulations Grant 8,614,255 - Blizzard , et al. December 24, 2 | 2013-12-24 |
Drug delivery through hydrogel plugs Grant 8,563,027 - Jarrett , et al. October 22, 2 | 2013-10-22 |
Drug Delivery Through Hydrogel Plugs App 20130172268 - Jarrett; Peter ;   et al. | 2013-07-04 |
Complex Of Trospium And Pharmaceutical Compositions Thereof App 20100272811 - Scher; David S. ;   et al. | 2010-10-28 |
Pulmonary Pharmaceutical Formulations App 20090105201 - Blizzard; Charles D. ;   et al. | 2009-04-23 |
Method and apparatus for producing dry particles App 20080108554 - Jackson; Blair C. ;   et al. | 2008-05-08 |
Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) App 20080063722 - Ward; Kevin L. ;   et al. | 2008-03-13 |
Method for administration of growth hormone via pulmonary delivery App 20050163725 - Blizzard, Charles D. ;   et al. | 2005-07-28 |
hGH (human growth hormone) formulations for pulmonary administration App 20040009231 - Jackson, Blair ;   et al. | 2004-01-15 |
Method and apparatus for producing dry particles App 20030222364 - Jackson, Blair C. ;   et al. | 2003-12-04 |
Sustained release microspheres App 20030059474 - Scott, Terrence L. ;   et al. | 2003-03-27 |
Sustained release microspheres Grant 6,458,387 - Scott , et al. October 1, 2 | 2002-10-01 |
Macromolecular microparticles and methods of production and use Grant 6,268,053 - Woiszwillo , et al. July 31, 2 | 2001-07-31 |
Macromolecular microparticles and methods of production and use Grant 6,090,925 - Woiszwillo , et al. July 18, 2 | 2000-07-18 |
Macromolecular microparticles and methods of production and use Grant 5,981,719 - Woiszwillo , et al. November 9, 1 | 1999-11-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.